Assignee
GW PHARMA LTD
GB·47 granted patents·49 pending applications·2,011 citations·filing 2001–2022
Top patents by PatentIndex Score
96 records- 0199US10807777B2Pharmaceutical formulationGW PHARMA LTD·Filed 2019·Granted Oct 20, 2020·38 cites·20 claims
- 0298US11311498B2Use of cannabinoids in the treatment of epilepsyGW PHARMA LTD·Filed 2015·Granted Apr 26, 2022·34 cites·21 claims
- 0398US10765643B2Use of cannabidiol in the treatment of epilepsyGW PHARMA LTD·Filed 2015·Granted Sep 8, 2020·35 cites·15 claims
- 0498US10538373B2Pharmaceutical formulationGW PHARMA LTD·Filed 2019·Granted Jan 21, 2020·11 cites·19 claims
- 0598US10195159B2Processes and apparatus for extraction of active substances and enriched extracts from natural productsGW PHARMA LTD·Filed 2015·Granted Feb 5, 2019·41 cites·5 claims
- 0698US10137095B2Use of cannabinoids in the treatment of epilepsyGW PHARMA LTD·Filed 2017·Granted Nov 27, 2018·63 cites·8 claims
- 0798US10111840B2Use of cannabinoids in the treatment of epilepsyGW PHARMA LTD·Filed 2015·Granted Oct 30, 2018·67 cites·14 claims
- 0898US10092525B2Use of cannabinoids in the treatment of epilepsyGW PHARMA LTD·Filed 2017·Granted Oct 9, 2018·62 cites·8 claims
- 0998US9956185B2Use of cannabinoids in the treatment of epilepsyGW PHARMA LTD·Filed 2017·Granted May 1, 2018·71 cites·11 claims
- 1098US9956186B2Use of cannabinoids in the treatment of epilepsyGW PHARMA LTD·Filed 2017·Granted May 1, 2018·68 cites·11 claims
- 1198US9956183B2Use of cannabinoids in the treatment of epilepsyGW PHARMA LTD·Filed 2017·Granted May 1, 2018·69 cites·18 claims
- 1298US9956184B2Use of cannabinoids in the treatment of epilepsyGW PHARMA LTD·Filed 2017·Granted May 1, 2018·67 cites·12 claims
- 1398US9949937B2Use of cannabinoids in the treatment of epilepsyGW PHARMA LTD·Filed 2017·Granted Apr 24, 2018·64 cites·14 claims
- 1498US9522123B2Use of one or a combination of phyto-cannabinoids in the treatment of epilepsyGW PHARMA LTD·Filed 2014·Granted Dec 20, 2016·62 cites·13 claims
- 1598US7709536B2Pharmaceutical formulationGW PHARMA LTD·Filed 2005·Granted May 4, 2010·53 cites·10 claims
- 1698US7025992B2Pharmaceutical formulationsGW PHARMA LTD·Filed 2001·Granted Apr 11, 2006·110 cites·38 claims
- 1797US11318109B2Pharmaceutical composition comprising the phytocannabinoids cannabidivarin (CBDV) and cannabidiol (CBD)GW PHARMA LTD·Filed 2019·Granted May 3, 2022·17 cites·42 claims
- 1897US6946150B2Pharmaceutical formulationGW PHARMA LTD·Filed 2002·Granted Sep 20, 2005·92 cites·26 claims
- 1997US6730330B2Pharmaceutical formulationsGW PHARMA LTD·Filed 2001·Granted May 4, 2004·98 cites·16 claims
- 2096US12121499B2Pharmaceutical composition comprising the phytocannabinoids cannabidivarin (CBDV) and cannabidiol (CBD)GW PHARMA LTD·Filed 2022·Granted Oct 22, 2024·3 cites·22 claims
- 2196US12023305B2Use of the phytocannabinoid cannabidivarin (CBDV) in the treatment of epilepsyGW PHARMA LTD·Filed 2020·Granted Jul 2, 2024·9 cites·7 claims
- 2296US10799467B2Use of the phytocannabinoid cannabidivarin (CBDV) in the treatment of epilepsyGW PHARMA LTD·Filed 2015·Granted Oct 13, 2020·22 cites·6 claims
- 2396US9949936B2Use of cannabinoids in the treatment of epilepsyGW PHARMA LTD·Filed 2016·Granted Apr 24, 2018·54 cites·14 claims
- 2496US9474726B2Use of cannabinoids in the treatment of epilepsyGW PHARMA LTD·Filed 2015·Granted Oct 25, 2016·74 cites·8 claims
- 2596US7622140B2Processes and apparatus for extraction of active substances and enriched extracts from natural productsGW PHARMA LTD·Filed 2002·Granted Nov 24, 2009·107 cites·28 claims
- 2696US7344736B2Extraction of pharmaceutically active components from plant materialsGW PHARMA LTD·Filed 2002·Granted Mar 18, 2008·103 cites·21 claims
- 2795US9962341B2Active pharmaceutical ingredient (API) comprising cannabinoids for use in the treatment of cancerGW PHARMA LTD·Filed 2015·Granted May 8, 2018·27 cites·9 claims
- 2895US9029423B2Pharmaceutical formulationGW PHARMA LTD·Filed 2013·Granted May 12, 2015·18 cites·4 claims
- 2995US7968594B2Pharmaceutical compositions for the treatment of painGW PHARMA LTD·Filed 2005·Granted Jun 28, 2011·47 cites·12 claims
- 3094US11413266B2Use of cannabinoids in the treatment of inflammatory skin diseasesGW PHARMA LTD·Filed 2016·Granted Aug 16, 2022·15 cites·5 claims
- 3194US10758514B2Use of tetrahydrocannabinol and/or cannabidiol for increasing radiosensitivity in the treatment of a brain tumourGW PHARMA LTD·Filed 2018·Granted Sep 1, 2020·22 cites·7 claims
- 3294US9205063B2Cannabinoid-containing plant extracts as neuroprotective agentsGW PHARMA LTD·Filed 2014·Granted Dec 8, 2015·50 cites·1 claims
- 3393US9675579B2Tetrahydrocannabivarin for use in the treatment of nausea and vomitingGW PHARMA LTD·Filed 2014·Granted Jun 13, 2017·55 cites·12 claims
- 3492US10179683B2Pharmaceutical formulationGW PHARMA LTD·Filed 2015·Granted Jan 15, 2019·8 cites·16 claims
- 3591US10653641B2Use of cannabinoids in the treatment of mental disordersGW PHARMA LTD·Filed 2016·Granted May 19, 2020·15 cites·7 claims
- 3690US9669002B2Use for cannabinoidGW PHARMA LTD·Filed 2015·Granted Jun 6, 2017·13 cites·3 claims
- 3789US9675654B2Phytocannabinoids in the treatment of cancerGW PHARMA LTD·Filed 2014·Granted Jun 13, 2017·17 cites·1 claims
- 3887USD559396SSecure container for holding liquid medicamentsGW PHARMA LTD·Filed 2006·Granted Jan 8, 2008·39 cites·1 claims
- 3986US10039724B27-hydroxy cannabidiol (7-OH-CBD) for use in the treatment of non-alcoholic fatty liver disease (NAFLD)GW PHARMA LTD·Filed 2015·Granted Aug 7, 2018·15 cites·8 claims
- 4086US8034843B2Compositions comprising cannabinoids for treatment of nausea, vomiting, emesis, motion sickness or like conditionsGW PHARMA LTD·Filed 2003·Granted Oct 11, 2011·25 cites·16 claims
- 4186US6929154B2Secure dispensing apparatusGW PHARMA LTD·Filed 2001·Granted Aug 16, 2005·43 cites·22 claims
- 4280US7246724B2Dispenser for receiving a cartridge of material having retractable pinsGW PHARMA LTD·Filed 2003·Granted Jul 24, 2007·28 cites·8 claims
- 4376US7537005B2Dose dispensing system and apparatusGW PHARMA LTD·Filed 2003·Granted May 26, 2009·59 cites·11 claims
- 4475US2020306328A1Extraction of pharmaceutically active components from plant materialsGW PHARMA LTD·Filed 2019·Application pending·0 cites
- 4571US11390437B2Pharmaceutical formulationGW PHARMA LTD·Filed 2020·Granted Jul 19, 2022·0 cites·15 claims
- 4671US2020206151A1Compositions comprising cannabinoids for treatment of nausea, vomiting, emesis, motion sickness or like conditionsGW PHARMA LTD·Filed 2019·Application pending·0 cites
- 4769US9421187B2Phytocannabinoids for use in the treatment of intestinal inflammatory diseasesGW PHARMA LTD·Filed 2012·Granted Aug 23, 2016·2 cites·9 claims
- 4869US2021128657A1Extraction of pharmaceutically active components from plant materialsGW PHARMA LTD·Filed 2020·Application pending·0 cites
- 4969US2020206184A1Pharmaceutical compositions for the treatment of disease and/or symptoms in arthritisGW PHARMA LTD·Filed 2019·Application pending·0 cites
- 5068US2019322427A1Pharmaceutical formulationGW PHARMA LTD·Filed 2019·Application pending·0 cites
Showing the top 50 of 96 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when GW PHARMA LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →